AYLA

Financial and hedge fund investment services; providing venture capital, development capital, private equity and investment funding; venture capital advisory services; pharmaceutical, medical, scientific, and biopharmaceutical research and development; providing medical and scientific research information in the field of pharmaceuticals; medical and scientific research in the fields of pharmaceuticals, genetics, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, and genetic diseases; software for genetic assessment and identification of cancer, diseases, health status and metrics, and gene mutations for scientific, medical, diagnostic, treatment, and research purposes; software used for the sequencing and analyses of genomic data, transcriptomic data, proteomic data, DNA, RNA, and protein; software used to predict, integrate and create data models; computer databases of genomic sequences for scientific research, namely, for tracking, matching, searching, testing, aggregating, researching, and evaluating health status, and diagnosing diseases and gene mutations; predictive digital computer modeling for analyzing and visualizing genomic data, and evaluating health status and diagnosing diseases, disorders, and syndromes; software for collecting, analyzing, reporting, and tracking data and information in the fields of genetics, genomics, biology, biochemistry